Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
G1 Execution Services, LLC DAVE Dave Inc. 13G 5.4% 6mo
METEORA CAPITAL, LLC ONCH 1RT Acquisition Corp. 13G/A 9.88% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ REXR Rexford Industrial Realty, Inc. 13G/A 12.6% 6mo
EMINENCE CAPITAL, LP LPX Louisiana-Pacific Corp 13G/A 3.6% 6mo
Cormorant Asset Management, LP CABA Cabaletta Bio, Inc. 13G/A 9.03% 6mo
AQR CAPITAL MANAGEMENT LLC LYFT Lyft, Inc. 13G/A 2.98% 6mo
WELLINGTON MANAGEMENT GROUP LLP SPRB Spruce Biosciences, Inc. 13G/A 3.6% 6mo
WELLINGTON MANAGEMENT GROUP LLP CCS Century Communities, Inc. 13G/A 3.1% 6mo
Jabbok Schlacks EQPT EquipmentShare.com Inc 13G 14.9% 6mo
Vestal Point Capital, LP DRUG Bright Minds Biosciences Inc. 13G 5% 6mo
Scott Farquhar TEAM Atlassian Corp 13G/A 22.7% 6mo
WELLINGTON MANAGEMENT GROUP LLP SHAK Shake Shack Inc. 13G/A 4.3% 6mo
Atreides Management, LP ACVA ACV Auctions Inc. 13G/A 5.6% 6mo
AMERIPRISE FINANCIAL INC QTRX Quanterix Corp 13G/A 7.5% 6mo
Venrock Healthcare Capital Partners III, L.P. SRZN Surrozen, Inc. 13G/A 9.9% 6mo
PERCEPTIVE ADVISORS LLC XFOR X4 Pharmaceuticals, Inc 13G/A 7.3% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ WING Wingstop Inc. 13G/A 6.6% 6mo
Iroquois Capital Management, LLC IVDA Iveda Solutions, Inc. 13G/A 4.99% 6mo
Fairbanks Jonathan B. FLOC Flowco Holdings Inc. 13G/A 41.3% 6mo
TCG Crossover GP II, LLC GLUE Monte Rosa Therapeutics, Inc. 13G/A 5.5% 6mo
Rubric Capital Management LP SDGR Schrodinger, Inc. 13G/A 9.28% 6mo
First Trust Capital Management L.P. SIMA SIM Acquisition Corp. I 13G/A 5.63% 6mo
CITADEL ADVISORS LLC ACRV Acrivon Therapeutics, Inc. 13G/A 0% 6mo
WELLINGTON MANAGEMENT GROUP LLP MYFW First Western Financial Inc 13G 5.3% 6mo
WELLINGTON MANAGEMENT GROUP LLP STOK Stoke Therapeutics, Inc. 13G 5.2% 6mo
VAN ECK ASSOCIATES CORP HL Hecla Mining Co 13G/A 5.32% 6mo
WELLINGTON MANAGEMENT GROUP LLP TRGP Targa Resources Corp. 13G/A 7% 6mo
Kenneth Griffin CORZ Core Scientific, Inc. 13G/A 4.1% 6mo
OceanLink Partners Fund, LP HUYA HUYA Inc. 13G/A 8.8% 6mo
Dellora Investments LP TENX Tenax Therapeutics, Inc. 13G/A 2.3% 6mo
Lan Huang BYSI BeyondSpring Inc. 13G/A 14.1% 6mo
ARMISTICE CAPITAL, LLC ARTL Artelo Biosciences, Inc. 13G 9.99% 6mo
ARMISTICE CAPITAL, LLC TVTX Travere Therapeutics, Inc. 13G 5.27% 6mo
METEORA CAPITAL, LLC BDCI BTC Development Corp. 13G/A 7.52% 6mo
Venrock Healthcare Capital Partners III, L.P. ZURA Zura Bio Ltd 13G/A 9.9% 6mo
Linonia Partnership LP GWRE Guidewire Software, Inc. 13G/A 9% 6mo
FIG LLC NN Nextnav Inc. 13G/A 15.3% 6mo
COHEN & STEERS, INC. ESS Essex Property Trust, Inc. 13G/A 7.53% 6mo
ARMISTICE CAPITAL, LLC RIGL Rigel Pharmaceuticals Inc 13G 6.93% 6mo
COHEN & STEERS, INC. EPRT Essential Properties Realty Trust, Inc. 13G/A 14.16% 6mo
AQR CAPITAL MANAGEMENT LLC TXRH Texas Roadhouse, Inc. 13G 5.49% 6mo
Ugur Sahin BNTX BioNTech SE 13G/A 15.8% 6mo
Azora Capital LP BRBS Blue Ridge Bankshares, Inc. 13G/A 3% 6mo
ROYAL BANK OF CANADA LBRDK Liberty Broadband Corp 13G/A 4.62% 6mo
METEORA CAPITAL, LLC CAEP Cantor Equity Partners III, Inc. 13G/A 9.7% 6mo
Alyeska Investment Group, L.P. SLMT Solmate Infrastructure PLC 13G/A 8.76% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ BAH Booz Allen Hamilton Holding Corp 13G 5.5% 6mo
VAN ECK ASSOCIATES CORP SLI Standard Lithium Ltd. 13G/A 7.74% 6mo
TENOR CAPITAL MANAGEMENT Co., L.P. CAQ Cambridge Acquisition Corp. 13G/A 4.3% 6mo
JANUS HENDERSON GROUP PLC DYN Dyne Therapeutics, Inc. 13G/A 8.3% 6mo